Roche immunotherapy cocktail boosts survival in liver cancer

Roche's Tecentriq immunotherapy mixed with the older cancer drug Avastin lifted both overall survival and progression-free survival in people with liver cancer that cannot be surgically removed, the Swiss drugmaker said on Monday.

from Reuters: Health News https://ift.tt/2oPWWgy
via IFTTT